PT2782559T - Composição farmacêutica compreendendo mio-inositol e d-quiro-inositol - Google Patents

Composição farmacêutica compreendendo mio-inositol e d-quiro-inositol

Info

Publication number
PT2782559T
PT2782559T PT12806356T PT12806356T PT2782559T PT 2782559 T PT2782559 T PT 2782559T PT 12806356 T PT12806356 T PT 12806356T PT 12806356 T PT12806356 T PT 12806356T PT 2782559 T PT2782559 T PT 2782559T
Authority
PT
Portugal
Prior art keywords
inositol
chiro
myo
pharmaceutical composition
pharmaceutical
Prior art date
Application number
PT12806356T
Other languages
English (en)
Inventor
Unfer Vittorio
Original Assignee
Lo Li Pharma Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45540947&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT2782559(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lo Li Pharma Srl filed Critical Lo Li Pharma Srl
Publication of PT2782559T publication Critical patent/PT2782559T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
PT12806356T 2011-11-22 2012-11-21 Composição farmacêutica compreendendo mio-inositol e d-quiro-inositol PT2782559T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000252A ITFI20110252A1 (it) 2011-11-22 2011-11-22 Composizione farmaceutica comprendente myo-inositolo e d-chiro-inositolo.

Publications (1)

Publication Number Publication Date
PT2782559T true PT2782559T (pt) 2018-10-15

Family

ID=45540947

Family Applications (1)

Application Number Title Priority Date Filing Date
PT12806356T PT2782559T (pt) 2011-11-22 2012-11-21 Composição farmacêutica compreendendo mio-inositol e d-quiro-inositol

Country Status (14)

Country Link
EP (2) EP2782559B1 (pt)
CY (1) CY1120438T1 (pt)
DK (1) DK2782559T3 (pt)
ES (1) ES2631988T3 (pt)
HR (1) HRP20181433T1 (pt)
IT (1) ITFI20110252A1 (pt)
LT (1) LT2782559T (pt)
PL (1) PL2782559T3 (pt)
PT (1) PT2782559T (pt)
RS (1) RS57607B1 (pt)
SA (1) SA112340015B1 (pt)
SI (1) SI2782559T1 (pt)
TW (1) TWI594750B (pt)
WO (1) WO2013076121A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112017000978A2 (pt) * 2014-08-08 2017-11-21 Nestec Sa mioinositol e probióticos e usos
WO2016020495A1 (en) * 2014-08-08 2016-02-11 Nestec S.A. Myo-inositol and one or more probiotic and use thereof
WO2016020486A1 (en) * 2014-08-08 2016-02-11 Nestec S.A. A combination of myo-inositol and zinc and its use
ITUA20162575A1 (it) * 2016-04-13 2017-10-13 S&R Farm S P A Composizione farmaceutica o nutraceutica per l’uso nel trattamento della sindrome dell’ovaio policistico o di malattie o disturbi correlati ad essa
US11898184B2 (en) * 2017-09-07 2024-02-13 Sweet Sense Inc. Low glycemic sugar composition
IT201700104446A1 (it) * 2017-09-19 2019-03-19 Lo Li Pharma Srl Compositions, uses and methods for treatment of infertility and subfertility
JP7257399B2 (ja) * 2017-11-23 2023-04-13 バイオサーチ、ソシエダッド、アノニマ 多嚢胞性卵巣症候群に罹患している女性患者における胚着床率を高める方法
PL238919B1 (pl) 2018-02-28 2021-10-18 Verco Spolka Akcyjna Kompozycja farmaceutyczna zawierająca mio-inozytol i D-chiro- inozytol, do zastosowania w terapeutycznym sposobie obniżania masy ciała u kobiet z zespołem policystycznych jajników
EP3840592A1 (en) * 2018-08-22 2021-06-30 Société des Produits Nestlé S.A. Composition comprising isomers of inositol and its use
EP3789018A1 (en) * 2019-09-09 2021-03-10 Servicio Andaluz De Salud Composition and methods for enhancing or promoting the secretion of ghrelin to promote a healthy metabolic aging
IT201900025063A1 (it) 2019-12-20 2021-06-20 Idi Integratori Dietetici Italiani S R L Composizioni gastroresistenti comprendi inositolo e/o estratto di gymnema sylvestre, loro composizioni farmaceutiche e nutraceutiche e loro uso
RU2757220C1 (ru) * 2020-06-03 2021-10-12 Общество с ограниченной ответственностью "ОКТАВА ХОЛДИНГ" Фармацевтическая композиция для профилактики и лечения синдрома поликистозных яичников
WO2022049433A1 (en) 2020-09-04 2022-03-10 Societe Des Produits Nestle Sa Compositions and methods for providing health benefits in an animal
EP4000626A1 (en) * 2020-11-16 2022-05-25 concrete flowers GmbH Pharmaceutical preparation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750348A (en) * 1989-03-08 1998-05-12 The University Of Virginia Patents Foundation Method for detecting insulin resistance
US5906979A (en) * 1998-01-27 1999-05-25 Insmed Pharmaceuticals, Inc. Compositions and methods for treating metabolic diseases characterized by hyperandrogenism and/or anovulation and/or infertility
EP1221865B1 (en) * 1999-10-18 2007-01-03 Muscletech Research and Development Inc. Food supplement for increasing lean mass and strength
JP2006213684A (ja) * 2005-02-07 2006-08-17 Hokko Chem Ind Co Ltd インスリン抵抗性改善に用いられる組成物及び健康用食品
ITRM20070341A1 (it) * 2007-06-20 2008-12-21 Lo Li Pharma Srl Formulazione integrativa inofolic finalizzata al controllo dell'induzione dell'ovulazione in programmi di procreazione medicalmente assistita

Also Published As

Publication number Publication date
TWI594750B (zh) 2017-08-11
ES2631988T1 (es) 2017-09-07
SA112340015B1 (ar) 2016-01-21
TW201320992A (zh) 2013-06-01
LT2782559T (lt) 2018-06-25
DK2782559T3 (en) 2018-08-27
EP2782559A1 (en) 2014-10-01
EP2782559B1 (en) 2018-06-06
ES2631988T3 (es) 2018-07-12
SI2782559T1 (sl) 2018-09-28
PL2782559T3 (pl) 2018-12-31
HRP20181433T1 (hr) 2018-10-19
CY1120438T1 (el) 2019-07-10
WO2013076121A1 (en) 2013-05-30
RS57607B1 (sr) 2018-11-30
ITFI20110252A1 (it) 2013-05-23
EP3424497A1 (en) 2019-01-09

Similar Documents

Publication Publication Date Title
HRP20181433T1 (hr) Farmaceutski pripravak koji sadrži mio-inozitol i d-chiro-inozitol
AP3864A (en) Pharmaceutical composition
HK1195793A1 (zh) 結合藥物組合物及其用途
HK1196924A1 (en) Structure containing volatile medicinal agent
ZA201501930B (en) Pharmaceutical composition
HK1206595A1 (en) Pharmaceutical compositions comprising benzyl alcohol
GB201118232D0 (en) Pharmaceutical composition
EP2832730A4 (en) MIRABEGRAPHIC PHARMACEUTICAL COMPOSITION
IL229677A0 (en) A liquid pharmaceutical preparation containing nitisinone
HK1189158A1 (en) Pharmaceutical composition
EP2769718A4 (en) MEDICINAL COMPOSITION
EP2775831A4 (en) PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
GB2504390B (en) Nutraceutical and pharmaceutical composition
IL229417A0 (en) A pharmaceutical preparation containing fexofenadine
EP2727593A4 (en) PHARMACEUTICAL COMPOSITION CONTAINING NICORANDIL
PL3097920T3 (pl) Kompozycja medyczna zawierająca ekstrakt stauntonia hexaphylla
EP2711010A4 (en) PHARMACEUTICAL COMPOSITION
GB2502232B (en) Medicine compositions containing vitamin D and metformin
HUP1100444A2 (en) Pharmaceutical composition
ZA201502987B (en) Pharmaceutical composition
EP2897590A4 (en) PHARMACEUTICAL COMPOSITION
EP2851078A4 (en) PHARMACEUTICAL COMPOSITION
PL2709599T3 (pl) Kompozycja farmaceutyczna zawierająca drotawerynę
HUP1100445A2 (en) Pharmaceutical composition
ZA201309537B (en) Pharmaceutical composition comprising fexofedine